Recent Updates
Recently added Catalysts
PTCT Positive Sentiment

PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

Key Takeaway: PTC Therapeutics, Inc. will host a webcast on May 7, 2026, to report its first quarter financial results. The call will also provide updates on the company's business strategies and outlook. Interested parties can access the live webcast through the company's website, with a replay available for 30 days post-event.
Price reaction · baseline $70.63 (2026-04-21 close) · hit after-hours · clean, no other PTCT news in the window
day 0 close
+0.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • PTC Therapeutics is hosting a financial results call, indicating ongoing business activity.
  • The company is committed to providing updates on its business and outlook.
  • PTC has a diversified pipeline aimed at addressing rare disorders.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+74%
120-day peak, hindsight
Typical move
6.6%
average across 4 past catalysts
Lead asset
Ataluren
Phase 3 · Cystic Fibrosis

Full Press Release Details

WARREN, N.J.,April 22, 2026/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ:PTCT) announced today that the company will host a webcast conference call to report its first quarter 2026 financial results and provide an update on the company's business and outlook on Thursday, May 7, 2026, at 4:30 p.m. ET.
To access the live webcast, please visit the "Events & Presentations" page within the Investors section of thePTC website. A replay of the webcast will be available on the PTC website for 30 days following the event. To participate via phone, please register in advancehereto receive dial-in details.
ABOUT PTC THERAPEUTICS, INC.PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visitwww.ptcbio.comand follow us on LinkedIn, X, Instagram and Facebook.

Investors:Ellen Cavaleri+1 (615) 618-8228[email protected]

Media:Jeanine Clemente+1 (908) 912-9406[email protected]

Frequently Asked Questions

When will PTC Therapeutics report its Q1 2026 results?

PTC Therapeutics will report its Q1 2026 financial results on May 7, 2026.

How can I access the PTC financial results webcast?

You can access the webcast through the 'Events & Presentations' page on the PTC website.

Is there a replay available for the webcast?

Yes, a replay of the webcast will be available for 30 days after the event.

What is the focus of PTC Therapeutics?

PTC Therapeutics focuses on developing medicines for rare disorders.

Last updated: Apr 22, 2026